Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia

In the past decade, novel targeted therapy approaches, such as BTK inhibitors and Bcl2 blockers, and innovative treatments that regulate the immune response against cancer cells, such as monoclonal antibodies, CAR-T cell therapy, and immunomodulatory molecules, have been established to provide suppo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepe, Felice, Balatti, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074107/
https://www.ncbi.nlm.nih.gov/pubmed/32098192
http://dx.doi.org/10.3390/jcm9020593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074107/
https://www.ncbi.nlm.nih.gov/pubmed/32098192
http://dx.doi.org/10.3390/jcm9020593

Ejemplares similares